|
1
|
Makki N, Brennan TM and Girotra S: Acute
coronary syndrome. J Intensive Care Med. 30:186–200.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Grech ED and Ramsdale DR: Acute coronary
syndrome: Unstable angina and non-ST segment elevation myocardial
infarction. BMJ. 326:1259–1261. 2003.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wachira JK and Stys TP: Cardiovascular
disease and bridging the diagnostic gap. S D Med. 66:366–369.
2013.PubMed/NCBI
|
|
4
|
Ofori-Asenso R, Zomer E, Chin KL, Markey
P, Si S, Ademi Z, Curtis AJ, Zoungas S and Liew D: Prevalence and
impact of non-cardiovascular comorbidities among older adults
hospitalized for non-ST segment elevation acute coronary syndrome.
Cardiovasc Diagn Ther. 9:250–261. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dai X, Busby-Whitehead J and Alexander KP:
Acute coronary syndrome in the older adults. J Geriatr Cardiol.
13:101–108. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mao X, Zhu R, Zhang F, Zhong Y, Yu K, Wei
Y, Sun H, Xu W, Luo Q, Wang Y, et al: IL-37 Plays a beneficial role
in patients with acute coronary syndrome. Mediators Inflamm.
2019(9515346)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Vroegindewey MM, Oemrawsingh RM, Kardys I,
Asselbergs FW, van der Harst P, Oude Ophuis AJ, Etienne Cramer G,
Maas A, Hong Kie The S, Wardeh AJ, et al: The temporal pattern of
immune and inflammatory proteins prior to a recurrent coronary
event in post-acute coronary syndrome patients. Biomarkers.
24:199–205. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wyss CA, Neidhart M, Altwegg L, Spanaus
KS, Yonekawa K, Wischnewsky MB, Corti R, Kucher N, Roffi M, Eberli
FR, et al: Cellular actors, Toll-like receptors, and local cytokine
profile in acute coronary syndromes. Eur Heart J. 31:1457–1469.
2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Laurell CB and Eriksson S: The
electrophoretic pattern α1-globulin pattern of serum in
α1-antitrypsin deficiency. 1963. COPD. 10 (Suppl 1):S3–S8.
2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ma H, Lu Y, Li H, Campbell-Thompson M,
Parker M, Wasserfall C, Haller M, Brantly M, Schatz D, Atkinson M
and Song S: Intradermal alpha1-antitrypsin therapy avoids fatal
anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia
in the NOD mouse model of the disease. Diabetologia. 53:2198–2204.
2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Reeves EP, Dunlea DM, McQuillan K, O'Dwyer
CA, Carroll TP, Saldova R, Akepati PR, Wormald MR, McElvaney OJ,
Shutchaidat V, et al: Circulating truncated alpha-1 antitrypsin
glycoprotein in patient plasma retains anti-inflammatory capacity.
J Immunol. 202:2240–2253. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen YH, Wu KJ, Wu KL, Wu KL, Tsai HM,
Chen ML, Chen YW, Hsieh W, Lin CM and Wang Y: Recombinant
adeno-associated virus-mediated expression of methamphetamine
antibody attenuates methamphetamine-induced hyperactivity in mice.
Sci Rep. 7(46301)2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Knoell DL, Ralston DR, Coulter KR and
Wewers MD: Alpha 1-antitrypsin and protease complexation is induced
by lipopolysaccharide, interleukin-1beta, and tumor necrosis
factor-alpha in monocytes. Am J Respir Crit Care Med. 157:246–255.
1998.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Abecassis A, Schuster R, Shahaf G, Ozeri
E, Green R, Ochayon DE, Rider P and Lewis EC: α1-antitrypsin
increases interleukin-1 receptor antagonist production during
pancreatic islet graft transplantation. Cell Mol Immunol.
11:377–386. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gottlieb PA, Alkanani AK, Michels AW,
Lewis EC, Shapiro L, Dinarello CA and Zipris D: α1-Antitrypsin
therapy downregulates toll-like receptor-induced IL-1β responses in
monocytes and myeloid dendritic cells and may improve islet
function in recently diagnosed patients with type 1 diabetes. J
Clin Endocrinol Metab. 99:E1418–E1426. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang D, Huang J, Luo D, Feng X and Liu Y
and Liu Y: Glycosylation change of alpha-1-acid glycoprotein as a
serum biomarker for hepatocellular carcinoma and cirrhosis. Biomark
Med. 11:423–430. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hennawy MG, Elhosseiny NM, Sultan H,
Abdelfattah W, Akl Y, Sabry NA and Attia AS: The effect of
α1-antitrypsin deficiency combined with increased
bacterial loads on chronic obstructive pulmonary disease
pharmacotherapy: A prospective, parallel, controlled pilot study. J
Adv Res. 7:1019–1028. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dichtl W, Moraga F, Ares MP, Crisby M,
Nilsson J, Lindgren S and Janciauskiene S: The carboxyl-terminal
fragment of alpha1-antitrypsin is present in atherosclerotic
plaques and regulates inflammatory transcription factors in primary
human monocytes. Mol Cell Biol Res Commun. 4:50–61. 2000.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhao Z, Ma J, Mao Y, Dong L, Li S and
Zhang Y: Silence of α1-Antitrypsin inhibits migration and
proliferation of triple negative breast cancer cells. Med Sci
Monit. 24:6851–6860. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Song S: Alpha-1 antitrypsin therapy for
autoimmune disorders. Chronic Obstr Pulm Dis. 5:289–301.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhao H, Liu H, Chai L, Xu P, Hua L, Guan
XY, Duan B, Huang YL and Li YS: Plasma α1-antitrypsin: A neglected
predictor of angiographic severity in patients with stable angina
pectoris. Chin Med J (Engl). 128:755–761. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gensini GG: A more meaningful scoring
system for determining the severity of coronary heart disease. Am J
Cardiol. 51(606)1983.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Khera AV and Kathiresan S: Genetics of
coronary artery disease: Discovery, biology and clinical
translation. Nat Rev Genet. 18:331–344. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Khera AV, Emdin CA, Drake I, Natarajan P,
Bick AG, Cook NR, Chasman DI, Baber U, Mehran R, Rader DJ, et al:
Genetic risk, adherence to a healthy lifestyle, and coronary
disease. N Engl J Med. 375:2349–2358. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Huxley RR, Hirakawa Y, Hussain MA,
Aekplakorn W, Wang X, Peters SA, Mamun A and Woodward M: Age- and
Sex-specific burden of cardiovascular disease attributable to 5
major and modifiable risk factors in 10 asian countries of the
western pacific region. Circ J. 79:1662–1674. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Foody J, Huo Y, Ji L, Zhao D, Boyd D, Meng
HJ, Shiff S and Hu D: Unique and varied contributions of
traditional CVD risk factors: A systematic literature review of CAD
risk factors in China. Clin Med Insights Cardiol. 7:59–86.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xu Y, Ye J, Wang M, Liu J, Wang Z, Jiang
H, Ye D, Zhang J and Wan J: The expression of interleukin-25
increases in human coronary artery disease and is associated with
the severity of coronary stenosis. Anatol J Cardiol. 23:151–159.
2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Peikert A, Kaier K, Merz J, Manhart L,
Schafer I, Hilgendorf I, Hehn P, Wolf D, Willecke F, Sheng X, et
al: Residual inflammatory risk in coronary heart disease: Incidence
of elevated high-sensitive CRP in a real-world cohort. Clin Res
Cardiol. 109:315–323. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Blaum C, Brunner FJ, Kroger F, Braetz J,
Lorenz T, Goßling A, Ojeda F, Koester L, Karakas M, Zeller T, et
al: Modifiable lifestyle risk factors and C-reactive protein in
patients with coronary artery disease: Implications for an
anti-inflammatory treatment target population. Eur J Prev Cardiol:
Nov 10, 2019 doi: 10.1177/2047487319885458 (Epub ahead of
print).
|
|
30
|
Zorlu C and Koseoglu C: Comparison of the
relationship between inflammatory markers and contrast-induced
nephropathy in patients with acute coronary syndrome after coronary
angiography. Angiology. 71:249–255. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Toniatti C, Demartis A, Monaci P, Nicosia
A and Ciliberto G: Synergistic trans-activation of the human
C-reactive protein promoter by transcription factor HNF-1 binding
at two distinct sites. EMBO J. 9:4467–4475. 1990.PubMed/NCBI
|
|
32
|
Majello B, Arcone R, Toniatti C and
Ciliberto G: Constitutive and IL-6-induced nuclear factors that
interact with the human C-reactive protein promoter. EMBO J.
9:457–465. 1990.PubMed/NCBI
|
|
33
|
Taylor AW, Ku NO and Mortensen RF:
Regulation of cytokine-induced human C-reactive protein production
by transforming growth factor-beta. Immunol. 145:2507–2513.
1990.PubMed/NCBI
|
|
34
|
Zhang Y, Shao T, Yao L, Yue H and Zhang Z:
Effects of tirofiban on stent thrombosis, Hs-CRP, IL-6 and sICAM-1
after PCI of acute myocardial infarction. Exp Ther Med.
16:3383–3388. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Janciauskiene SM, Bals R, Koczulla R,
Vogelmeier C, Kohnlein T and Welte T: The discovery of
α1-antitrypsin and its role in health and disease. Respir Med.
105:1129–1139. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gooptu B, Dickens JA and Lomas DA: The
molecular and cellular pathology of α1-antitrypsin deficiency.
Trends Mol Med. 20:116–127. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Stockley RA and Turner AM: α-1-Antitrypsin
deficiency: Clinical variability, assessment, and treatment. Trends
Mol Med. 20:105–115. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Fregonese L and Stolk J: Hereditary
alpha-1-antitrypsin deficiency and its clinical consequences.
Orphanet J Rare Dis. 3(16)2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ferrarotti I, Thun GA, Zorzetto M,
Ottaviani S, Imboden M, Schindler C, von Eckardstein A, Rohrer L,
Rochat T, Russi EW, et al: Serum levels and genotype distribution
of α1-antitrypsin in the general population. Thorax. 67:669–674.
2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Gilutz H, Siegel Y, Paran E, Cristal N and
Quastel MR: Alpha 1-antitrypsin in acute myocardial infarction. Br
Heart J. 49:26–29. 1983.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Brunetti ND, Correale M, Pellegrino PL,
Cuculo A and Biase MD: Acute phase proteins in patients with acute
coronary syndrome: Correlations with diagnosis, clinical features,
and angiographic findings. Eur J Intern Med. 18:109–117.
2007.PubMed/NCBI View Article : Google Scholar
|
